The companies who know how to use AI effectively aren’t laying off entire teams. They’re rethinking how work gets done.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Biologics developers are caught in a paradox: demand for therapies is climbing, but the industry faces constant pressure to cut costs and move faster.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $314.75, a high estimate of $340.00, and a low estimate of $290.00. Witnessing a ...

To ensure security, scalability and agility, many organizations are migrating to the cloud to unify data, reduce costs and ...

Learn how to work with streaming data using Microsoft Fabric, KQL, and Real-Time Intelligence in this full-day Live! 360 ...

Command Alkon, the leading software and solutions provider for the heavy building materials industry, reaffirms its commitment to batch innovation and enhancing the efficiency and precision of ...

The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...

The rStar2-Agent framework boosts a 14B model to outperform a 671B giant, offering a path to state-of-the-art AI without ...

Regulatory requirements such as the EU’s Digital Operational Resilience Act (DORA) underscore the need for financial institutions to improve their resilience to very real threats such as cyberattacks, ...

Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a business update and provides its final audited financial results ...

Command Alkon, the leading software and solutions provider for the heavy building materials industry, reaffirms its commitment to batch innovation and enhancing the efficiency and precision of ...